These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10770354)

  • 1. Effects of high-dose intravenous immunoglobulin on virus load in HIV-infected children.
    Church JA; Fox S; Gomperts E
    J Acquir Immune Defic Syndr; 1999 Nov; 22(3):309-11. PubMed ID: 10770354
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Mofenson LM; Moye J; Bethel J; Hirschhorn R; Jordan C; Nugent R
    JAMA; 1992 Jul 22-29; 268(4):483-8. PubMed ID: 1352363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience with the use of immune intravenous immunoglobulin in symptomatic children with human immunodeficiency virus infection].
    Jiménez E; Carrer MT; Pérez Dieppa I; Ortiz L; Fernández M
    Bol Asoc Med P R; 1991 Dec; 83(12):538-42. PubMed ID: 1811606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine therapy in combination with intravenous immunoglobulin in HIV infected children.
    Croft N; Yap PL; Mok JY; Hague RA; Burns SM
    Scott Med J; 1992 Oct; 37(5):138-41. PubMed ID: 1362818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).
    Stiehm ER; Fletcher CV; Mofenson LM; Palumbo PE; Kang M; Fenton T; Sapan CV; Meyer WA; Shearer WT; Hawkins E; Fowler MG; Bouquin P; Purdue L; Sloand EM; Nemo GJ; Wara D; Bryson YJ; Starr SE; Petru A; Burchett S
    J Infect Dis; 2000 Feb; 181(2):548-54. PubMed ID: 10669338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of intravenous 7S immunoglobulins at high doses in HIV-related immunological pathology].
    Fiori GP
    Clin Ter; 1994 Apr; 144(4):301-5. PubMed ID: 8205754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Mofenson LM; Harris DR; Rich K; Meyer WA; Read JS; Moye J; Nugent RP; Korelitz J; Bethel J; Pahwa S
    AIDS; 1999 Jan; 13(1):31-9. PubMed ID: 10207542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporarily controlled HIV-1 replication after intravenous immunoglobulin treatment of Guillain-Barré syndrome.
    Gisslén M; Fredman P; Fuchs D; Lekman A; Rosengren L
    Scand J Infect Dis; 2005; 37(11-12):877-81. PubMed ID: 16308224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulins and left ventricular structure and function in pediatric HIV infection.
    Lipshultz SE; Orav EJ; Sanders SP; Colan SD
    Circulation; 1995 Oct; 92(8):2220-5. PubMed ID: 7554205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of polyclonal intravenous immunoglobulin in treating HIV-infected children with severe bacterial infections: a retrospective cohort study.
    Huang LC; Myer L; Jaspan HB
    BMC Infect Dis; 2008 Sep; 8():127. PubMed ID: 18811982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin in symptomatic and asymptomatic children with perinatal HIV infection.
    Olopoenia L; Young M; White D; Barnes S; Rahbar F; Fomufod A
    J Natl Med Assoc; 1997 Aug; 89(8):543-7. PubMed ID: 9264222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for intravenous immunoglobulins].
    Spertini F
    Rev Med Suisse Romande; 1993 Mar; 113(3):179-82. PubMed ID: 8480110
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of acute pneumonia in human immunodeficiency virus-infected children and association with long term mortality risk. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Mofenson LM; Yogev R; Korelitz J; Bethel J; Krasinski K; Moye J; Nugent R; Rigau-Perez JG
    Pediatr Infect Dis J; 1998 Oct; 17(10):872-80. PubMed ID: 9802627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does intravenous immune globulin have a role in HIV-infected patients?
    Yap PL
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):59-67. PubMed ID: 8033437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Mofenson LM; Moye J; Korelitz J; Bethel J; Hirschhorn R; Nugent R
    Pediatr Infect Dis J; 1994 Jun; 13(6):477-84. PubMed ID: 8078734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection.
    Mofenson LM; Moye J
    Pediatr Res; 1993 Jan; 33(1 Suppl):S80-7; discussion S87-9. PubMed ID: 8433880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of short-term withdrawal of i.v. immunoglobulin therapy for selected children with human immunodeficiency virus infection.
    Grisaru-Soen G; Lau W; Arneson C; Louch D; Bitnun A; Stephens D; Read SE; King SM
    Pediatr Int; 2007 Dec; 49(6):972-7. PubMed ID: 18045306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of intravenous immunoglobulins in symptomatic HIV infection. Results of a randomized study.
    Jablonowski H; Sander O; Willers R; Adams O; Bartmann P; Wahn V
    Clin Investig; 1994 Feb; 72(3):220-4. PubMed ID: 7912123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of HIV infection in infancy.
    Connor E; McSherry G
    Clin Perinatol; 1994 Mar; 21(1):163-77. PubMed ID: 7912175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group.
    Lambert JS; Mofenson LM; Fletcher CV; Moye J; Stiehm ER; Meyer WA; Nemo GJ; Mathieson BJ; Hirsch G; Sapan CV; Cummins LM; Jimenez E; O'Neill E; Kovacs A; Stek A
    J Infect Dis; 1997 Feb; 175(2):283-91. PubMed ID: 9203648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.